PMID- 24012102 OWN - NLM STAT- MEDLINE DCOM- 20140513 LR - 20201206 IS - 1573-2517 (Electronic) IS - 0165-0327 (Linking) VI - 151 IP - 2 DP - 2013 Nov TI - High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker? PG - 738-743 LID - S0165-0327(13)00630-7 [pii] LID - 10.1016/j.jad.2013.07.041 [doi] AB - OBJECTIVES: Neurotrophic factors exert substantial effects on the central nervous system. The present study investigates the roles of insulin-like growth factor-1 (IGF-1), beta-nerve growth factor (beta-NGF), and brain-derived neurotrophic factor (BDNF) in bipolar disorder. METHODS: Baseline levels of culture-stimulated IGF-1, beta-NGF, and BDNF were compared in 116 patients with bipolar I disorder and 123 healthy controls. Neurotrophic factors were also compared in patients before and after 6 weeks of pharmacotherapy. A multivariate logistic regression analysis was used to investigate the influence of the neurotrophic factors analyzed in quartile form, in relation to confounding variables, such as age, sex, and body mass index. RESULTS: IGF-1 was significantly higher in patients (mean=514.57, SD=259.78) than in healthy controls (mean=316.82, SD=270.00, p<0.0001) at baseline. Furthermore, higher levels of IGF-1 substantially increased the risk for bipolar I disorder. IGF-1 level was not significantly changed at 6-weeks (mean=506.41, SD=313.66). No changes in BDNF or beta-NGF-1 levels were found following the 6-week treatment period. IGF-1 and beta-NGF were negatively correlated in healthy controls, but not in patients. Severity of manic symptoms was not associated with any of the neurotrophic factors. LIMITATIONS: We did not measure cortisol, growth hormone, or IGF-1 receptors. This study is cross-sectional in design. CONCLUSIONS: Elevated IGF-1 levels may be a trait marker for bipolar disorder. Further studies are needed to thoroughly investigate the role of IGF-1 in relation to other neuroendocrine factors and biological markers for bipolar disorder. CI - (c) 2013 Elsevier B.V. All rights reserved. FAU - Kim, Yong-Ku AU - Kim YK AD - Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea. FAU - Na, Kyoung-Sae AU - Na KS AD - Department of Psychiatry, Gachon University Gil Medical Center, 1198, Guwol-dong, Namdong-Gu, Incheon, Republic of Korea. Electronic address: ksna13@gmail.com. FAU - Hwang, Jung-A AU - Hwang JA AD - Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea. FAU - Yoon, Ho-Kyoung AU - Yoon HK AD - Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea. FAU - Lee, Heon-Jeong AU - Lee HJ AD - Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea. FAU - Hahn, Sang-Woo AU - Hahn SW AD - Department of Psychiatry, College of Medicine, Soonchunhyang University, Seoul, Republic of Korea. FAU - Lee, Bun-Hee AU - Lee BH AD - Department of Psychiatry, Gangnam Eulji Hospital, Eulji University, Seoul, Republic of Korea. FAU - Jung, Han-Yong AU - Jung HY AD - Department of Psychiatry, College of Medicine, Soonchunhyang University, Seoul, Republic of Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130822 PL - Netherlands TA - J Affect Disord JT - Journal of affective disorders JID - 7906073 RN - 0 (Biomarkers) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 9061-61-4 (Nerve Growth Factor) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Biomarkers/blood MH - Bipolar Disorder/*blood/drug therapy MH - Brain-Derived Neurotrophic Factor/*blood MH - Cross-Sectional Studies MH - Female MH - Humans MH - Insulin-Like Growth Factor I/*analysis MH - Male MH - Middle Aged MH - Nerve Growth Factor/*blood MH - Young Adult OTO - NOTNLM OT - Bipolar disorder OT - Brain-derived neurotrophic factor OT - Insulin-like growth factor-1 OT - Nerve growth factor OT - Neurotrophin EDAT- 2013/09/10 06:00 MHDA- 2014/05/14 06:00 CRDT- 2013/09/10 06:00 PHST- 2013/05/02 00:00 [received] PHST- 2013/07/28 00:00 [revised] PHST- 2013/07/30 00:00 [accepted] PHST- 2013/09/10 06:00 [entrez] PHST- 2013/09/10 06:00 [pubmed] PHST- 2014/05/14 06:00 [medline] AID - S0165-0327(13)00630-7 [pii] AID - 10.1016/j.jad.2013.07.041 [doi] PST - ppublish SO - J Affect Disord. 2013 Nov;151(2):738-743. doi: 10.1016/j.jad.2013.07.041. Epub 2013 Aug 22.